Anti-CLDN6 (AB1-11) (A3158-GRP)

Anti-CLDN6 (AB1-11) is a monoclonal antibody targeting the tumor-associated antigen (TAA) Claudin 6 (CLDN6). It enhances malignant potentials and drug resistance of cervical ADC and can provide a new therapeutic strategy for uterine cervical adenocarcinoma. MW :144.66 KD.